siRNA

Rona buys siRNA platform, 4 preclinical liver drugs from Sanofi

Shanghai-based Rona is using some of its money to acquire a small interfering RNA platform and four preclinical candidates from Sanofi.

James Waldron Jul 25, 2022 8:41am

Boehringer OKs $100M biobucks deal for hearing loss R&D project

Apr 13, 2022 8:00am

Northwestern U's novel RNA drug shows promise in brain cancer

Mar 10, 2021 2:00pm

Sirnaomics nabs a major $105M funding round for RNA work

Oct 23, 2020 8:45am